Skip to content
GLP-1 Scorecard
Menu
Graded #202

Ivologist

Ivologist offers compounded semaglutide and tirzepatide starting at $33/week (12-week plans).

Visit IvologistWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$145/mo (compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

Weigh Ivologist against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Ivologist dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value71/100
Dose & formulation52/100
Clinical oversight84/100
Labs & monitoring53/100
Fulfillment85/100
Contract terms37/100

Strengths

  • LegitScript certified
  • All 50 states coverage
  • No monthly contracts, memberships, or autodrafts
  • Over 20,000 patients served
  • Both semaglutide and tirzepatide available

Where it loses points

  • No legal entity name or physical address disclosed on site
  • Broader platform — not a GLP-1 specialist
  • $25 deposit required to book the provider consultation (unclear whether it is credited toward the program)

Bottom line — Grade C

Best for: Patients seeking contract-free compounded GLP-1 with nationwide coverage.

Ranked #202 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Ivologist — the realistic shortlist.

The 18 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Ivologist's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Ivologist's site. Not medical advice; see our disclosure.

← Back to the scorecard